David Vaughan
The Florey Co-Node Director
Related News
First dementia treatment drug approved for Australia, supported by NIF capacity
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
Network models brain changes in motor neurone disease to develop imaging tools for clinicians
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
Powerful software reveals brain superhighway ‘tracts’ for surgery and research
Our brains work a bit like highly advanced supercomputers, with bundles of white matter, known as ‘tracts,’ acting as superhighways that facilitate information flow and enable various brain functi
05 September 2024
Amazon: Empowering epilepsy patients to live fully with AWS Cloud
AWS’s Artificial Intelligence is helping the Australian Epilepsy Project better understand epilepsy, and support doctors and patients in Australia make the diagnosis, treatment, and management of th
25 August 2024